Author

S. Keadsanti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2

Frequent Co-Authors

A. L. Morrow· 1 shared A. Yamanaka· 1 shared D. S. Newburg· 1 shared J. Panachan· 1 shared K. Ikuta· 1 shared P. Pitaksajjakul· 1 shared P. Ramasoota· 1 shared S. Benjathummarak· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. L. Morrow

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Red blood cell-derived extracellular vesicles with miR-204 mimic loading for pediatric neuroblastoma treatment

W. Chiangjong, J. Panachan, S. Keadsanti, D. S. Newburg, A. L. Morrow, S. Hongeng, S. Chutipongtanate

This study develops red blood cell-derived extracellular vesicles loaded with miR-204 mimic to treat neuroblastoma, showing inhibitory effects on cell viability and spheroid growth.

bioRxiv · May 29, 2023 · PreprintBioengineering

Generation and therapeutic efficacy of the novel Fc-modified cross-neutralizing human monoclonal antibodies against dengue virus

S. Injampa, S. Benjathummarak, S. Keadsanti, W. Puangmanee, A. Yamanaka, T. Sasaki, K. Ikuta, P. Ramasoota, P. Pitaksajjakul

This paper develops two Fc-modified human monoclonal antibodies that neutralize all dengue virus serotypes without causing antibody-dependent enhancement or complement activation.

bioRxiv · May 25, 2023 · PreprintImmunology